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INTRODUCTION
Asthma is a common chronic respiratory disease. As of 2014, 
it was estimated to have afflicted 334 million people world-
wide.1 This was an increase of 100 million new sufferers within 
a decade from 2004 when there were 234.9 million sufferers. In 
that same year, the South-east Asia and Western Pacific regions 
accounted for 45.5% (45.7 and 61.2 million, respectively) of all 
sufferers.2 The chronic nature of the disease and the large num-
ber of sufferers can present a major economic and social bur-
den for countries in these regions.3 Asian studies of patients 
with asthma, which were conducted through face-to-face or 
phone interviews, addressed the burden of disease on the pa-
tient and their reactions to exacerbations caused by the dis-
ease.4-7 The 2014 REcognise Asthma and LInk to Symptoms and 
Experience (REALISE) Asia8 survey of patients with asthma, in-
stead, focused on their perceptions of asthma control, and atti-
tudes toward the disease and its treatment in an accessible, re-
al-life adult Asian population. It showed that many patients 
perceived their asthma to be controlled and not serious despite 
the presence of symptoms and exacerbations. A second RE-
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ALISE Asia survey of physicians who treated patients with asth-
ma showed that physicians also over-estimated the level of con-
trol among their patients.9,10 Physician-patient follow-up con-
sultations were short (average <10 minutes) and usually ver-
bal, with limited use of printed material. Real-life studies also 
showed that asthma control, as defined by the Global Initiative 
for Asthma (GINA)11 criteria, was poor and highlighted a com-
plex interaction of disease, doctor, patient and environment-re-
lated factors.8,12-14 As a result, the optimal levels of asthma con-
trol achieved in clinical studies could not be replicated in real-
life studies.15
Some tools are available to assist the physician in assessing 
the current level of asthma control and quality of life of the pa-
tient include the Asthma Control Test (ACT)16 and Asthma Con-
trol Questionnaire (ACQ).17 However, the ability of a patient to 
cope with a chronic disease, such as asthma, is influenced not 
only by its symptoms but also his personality profile and behav-
ioral characteristics.18-20 Thus, physicians should consider the 
patient’s psychological well-being and attitudes toward his/her 
disease besides treating the clinical symptoms of asthma as 
these can have an important bearing on the eventual treatment 
outcome.18,19,21,22 Indeed, Axelsson et al.23 have shown that per-
sonality traits can influence how asthma patients adhere to 
asthma treatment and report their asthma control and quality 
of life. Unfortunately, tools that can help physicians identify the 
attitudinal profile of their patients and the treatment approach 
appropriate to this profile are not readily available. Jones et al.24 
proposed a tool that can be used by physicians to compute the 
risk of having uncontrolled asthma based on patient attitudes 
toward medical professionals and the treatment for their asth-
ma. However, to our knowledge, the development of a tool that 
can segment the population into distinct attitudinal profiles 
and assist in personalizing and tailoring management ap-
proaches has not been previously attempted for asthma pa-
tients. 
In our REALISE Asia patient study (the results of which have 
been published8), an online survey was conducted among eli-
gible respondents from validated25 consumer panels in China, 
Hong Kong Special Administrative Region, Indonesia, South 
Korea, Malaysia, Philippines, Singapore, and Taiwan who used 
social media. The survey focused on patients’ perceptions of 
asthma control, and their attitudes toward the disease and its 
treatment in an accessible, real-life adult Asian population. The 
attitudinal data, collected from 2,467 respondents aged 18-50 
years who suffered from the disease, were analyzed and used to 
identify attitudinal control groupings or ‘clusters’ for patients 
with asthma. A factor analysis (also published26) was used to 
summarise responses to 27 attitude-related question items 
from the survey questionnaire into a set of 9 attitudinal factors, 
and established the linkage between these 9 factors and the ex-
tent to which they are correlated. Then, through a cluster analy-
sis, these respondents were grouped into clusters based on 
their ratings against these 9 factors. Each cluster described pa-
tients who were similar in their attitudes toward asthma but 
distinct from those in the other clusters. The result was 5 attitu-
dinal clusters: Cluster 1 (Well-adjusted and at least partly con-
trolled), Cluster 2 (In denial about symptoms), Cluster 3 (Adrift 
and poorly controlled), Cluster 4 (Tolerating with poor control), 
and Cluster 5 (Worried with multiple symptoms) which en-
compassed the whole spectrum of patient attitudes toward 
their asthma condition (Fig. 1).26
This manuscript describes the development and validation of 
a profiling tool that will identify which 1 of the 5 attitudinal clus-
ters identified above, a patient with asthma belongs. The 
knowledge of the cluster that a patient belongs to is expected to 
help healthcare professionals tailor the treatment approach to 
improve its outcome. At the time of this manuscript, there is an 
on-going study by an international panel of clinicians and al-
lied health professionals working from Europe and Asia to gen-
erate consensus asthma management recommendations for 
each of these attitudinal clusters.27
MATERIALS AND METHODS
We adopted a 2-step methodology: (1) to develop a Profiling 
Tool using a minimal list of question items from the REALISE 
Asia survey questionnaire that will accurately assign a patient 
to the correct attitudinal cluster, and (2) to validate this Profiling 
Tool using a split-sample procedure to confirm that its predic-
tive accuracy can be achieved in actual practice.
Development phase
Subjects
The REALISE Asia patient survey was done through email in-
vites to a random sample of individuals from validated con-
sumer panels between December 2013 and March 2014 asking 
them to complete a 30-minute online questionnaire.25 The sur-
vey included individuals aged 18-50 years who were diagnosed 
with asthma, given ≥2 asthma-related prescriptions in the past 
2 years (to ensure that individuals have active asthma) and had 
used social media. The following respondents were excluded 
from the survey: (1) those who were employed or had relatives 
employed in the healthcare, pharmaceutical, advertising or 
market research industries; and (2) those who had taken part in 
healthcare-related market research in the past 3 months.  The 
survey flowchart is reproduced and shown in Fig. 2.8
Item generation
The initial question set for the Profiling Tool consisted of the 
27 attitude-related questions from the survey questionnaire 
which were used for the factor analysis to determine the 5 pa-
tient attitudinal clusters26 (Supplementary Material, highlighted 
in blue, green, and yellow). In the survey, respondents were 
asked on their degree of agreement, i.e., ‘strongly disagree,’ ‘dis-
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agree,’ ‘tend to agree,’ and ‘strongly agree,’ to various statements 
about their asthma. However, we decided to dichotomize 
(agree/disagree) their responses to take into account the possi-
ble variation in response styles between countries due to their 
cultural differences. 
Item reduction
We set a range of 4-12 items as a viable number of questions 
that patients would be willing to answer in the Profiling Tool, 
which would also accurately identify a patient’s cluster mem-
bership. As the number of combinations of 4 to 12 items that 
can be selected from the 27 attitude-related questions was very 
large (>120 million), we used a multinomial logistic regression 
technique to exclude question items that were deemed to be 
poorer predictors of cluster membership on the basis of their 
Wald statistics (<35) to reduce this number. Starting from ques-
tion items with the highest Wald statistics, the smallest subset 
was drawn such that it contained at least 1 item from each of 
the 9 attitudinal factors which was used to obtain the attitudinal 
clusters.26 The selected subset consisted of 14 question items 
(namely, Q2: a3, a6, a9; Q34a2; Q39: a2, a6; Q46: a1, a2; and 
Q48: a2, a3, a5, a6, a7, a11; Supplementary Material, highlight-
ed in green and yellow). 
Discriminant function analysis (DFA) was used to determine 
whether this selected subset of question items (predictors) was 
effective in predicting the cluster membership of a given case.28 
Fig. 1. Patient attitudinal clusters.
Based on all respondents (n=2467), Clusters 1 (29%; n=713), 2 (18%; n=429), 3 (13%; n=332), 4 (29%; n=715), and  5 (11%; n=278)
Reproduced with permission: Cho SH, David-Wang A, et al. Identification of  Attitudinal Clusters in Patients with Asthma. Data presented in APSR Congress, 
November 2014, Bali, Indonesia (O-A-011)
Fig. 2. REALISE Asia patient survey flowchart.
Questionnaires
started (n=71,002)
Eligible respondents
included in final  
survey (n=2,467)
China - 800
Hong Kong - 200
Indonesia - 166
Korea - 500
Malaysia - 151
Philippines - 150
Singapore - 200
Taiwan - 300
Eligible respondents
who completed
questionnaire
(n=2,921)
Excluded
• Incomplete questionnaire (n=18,672)
• Failed inclustion criteria (n=49,409)
  •  Failed general screening criteria 
(n=11,022)
  •  Did not have asthma (n=37,505)
  •  Fewer than 2 prescriptions (n=837)
  •  Do not use social media (n=29)
  •  Did not give informed consent (n=16)
Excluded
• Failed data cleaning QC (n=454)
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The output from the DFA was a set of equations; 1 for each clus-
ter. Each equation contained the predictors and had a weight 
associated with each of them. The equation with the highest 
score for a case’s set of predictor values was that with the high-
est probability of being the cluster that the case belonged to. 
Besides the 14 question items which were to be answered by 
the patient, the level of asthma control (i.e., well-controlled, 
partly controlled, and uncontrolled) using the GINA-based 
Helping Asthma in Real-life Patients initiative (iHARP)29 criteria 
was added to provide an input from the physician. Three com-
binations using the question items and the iHARP classification 
for the level of asthma control were considered: (1) including 
the iHARP classification as a single co-variate; (2) using the in-
dividual iHARP items as co-variates; and (3) excluding the 
iHARP classification altogether.  We ran the DFA to test several 
formulations for each of these combinations, each time choos-
ing 12 or fewer question items from the 14 items available to 
satisfy our desired range of 4-12 items. The objective was to find 
the formulation with the lowest misclassification rate or con-
versely, the highest accuracy rate i.e., the predicted cluster com-
pared to the attitudinal cluster of the case which was known at 
the onset. We applied a rule-of-thumb of 75%30,31 as the mini-
mum accuracy to find the best formulations.
Validation phase
We used a split-sample procedure to validate the performance 
of our Profiling Tool. The original sample (2,400 cases) was di-
vided into 2 sub-samples: one for estimating the predictive 
model and the other validating the estimated model. This type 
of cross-validation technique is widely accepted as one that 
usefully assesses how the results of a predictive model can be 
generalised to an independent data set.32 We used a repeated 
2-fold random sub-sampling method to create independent 
sub-samples where each case had a 0.50 probability of being in 
the ‘estimation’ or ‘validation’ sub-samples. This meant that the 
‘estimation’ sub-sample would be approximately the same size 
(between 1,146 and 1,259 cases) as the ‘validation’ sub-sample.
We repeated the sub-sampling process 100 times. This was a 
compromise between (1) identifying the discriminant func-
tions for each of the 100 estimation sub-samples and profiling 
the validation sub-sample using that set of discriminant func-
tions which is time-consuming; and (2) having as many inde-
pendent estimates of the discriminant functions as possible to 
increase the overall accuracy of the predictive model. With 100 
estimates, we believed that we would have a sufficiently robust 
estimate of the 95% confidence intervals around the prediction.
We then ran the DFA on each of the 100 estimation sub-sam-
ples. We used the resultant set of discriminant functions to as-
sign the cases in the corresponding validation sample to their 
clusters. The outcome measure is the accuracy rate of the dis-
criminant functions in assigning the estimation and validation 
sub-samples to their attitudinal cluster, which was known at 
the onset.
RESULTS
Most (62.3%) of the respondents were in the 26-40 years age 
groups. Both sexes were almost equally represented, with males 
forming 53.7% of the population. At the country level, the per-
centage of males ranged from a low of 41.1% for Malaysia to a 
high of 60.0% for Korea. They also accessed social media fre-
quently with 85.0% of them using it 1 or more times daily. 
About 1 in 5 (17.8%) of the population had controlled asthma 
using the GINA-defined control status.11 Fig. 3 shows the demo-
graphic, socio-economic, and disease profiles of the respon-
dents by country and for the population as a whole. These pro-
files were similar across the countries except for the reported 
household occupation in China where there was a higher pro-
portion of respondents in the intermediate managerial catego-
ry. For the distribution of the attitudinal clusters, Clusters 1 and 
4 had the highest (28.9% and 29.0%, respectively) representa-
tion, while cluster 5 the least (11.3%). Fig. 4 shows the cluster 
distribution pattern for respondents in each of the surveyed 
countries and the total population. These cluster profiles were 
similar to each other. 
Development phase
Fig. 5 shows the accuracy rates for the DFA model which used 
the full sample of 2,400 cases from the REALISE Asia survey 
and had complete data for the question items of the Profiling 
Tool. The set of formulations using the iHARP classification as a 
single co-variate produced solutions with the best accuracy 
rates ranging from 70.1% to 77.5% depending on the number of 
question items used. The 11-predictor variables model (Fig. 5, 
circled brown); consisting of 10 question items (Supplementary 
Material, highlighted in yellow), and iHARP classification as a 
single variable was selected as the formulation that had the 
highest accuracy (77.2%, benchmark: 75.0%) while using a 
minimal number of question items. The question items in this 
formulation were applied to the Profiling Tool in the same se-
quence as in the original survey questionnaire so as to retain 
the order effect among the questions.
Final adjustments
We re-arranged the order of the questions by bringing forward 
the ‘stressful life’ question item (Q46a2) as it is related to the re-
spondent’s general situation rather than concerning their asth-
ma specifically or its treatment and by grouping the inhaler-re-
lated questions together (Q39a6, Q48a2-3). We excluded Q39a2 
(My doctor doesn’t understand my asthma) as we felt that it 
was a leading question on the patient-doctor relationship and 
replaced it with Q2a3 (I have no time to think about my health 
as other things are more important). The final list of questions 
was marginally less efficient (76.2% vs. 77.2%) (Table 1).
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Validation phase
Fig. 6 shows the predictive accuracies of the 100 validation 
runs, ordered independently by the estimation and the valida-
tion sub-samples, from the most to the least accurate. The blue 
line shows the accuracy rates of the estimation sub-samples, 
each with an error bar (also in blue) denoting the 95% confi-
Fig. 3. Demographic, socio-economic, and disease profiles by country.
Fig. 4. Attitudinal cluster profile by country.
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dence intervals for that accuracy rate. The accuracy rates 
ranged from 74.8% to 78.7% (average 76.7%) with reference to 
the original attitudinal cluster of each case. The ordered accu-
racy rates for the validation sub-samples, which ranged from 
72.3% to 78.3% (average 75.3%), were about 1.4 percentage 
points lower compared to the ordered rates for estimation sub-
samples (Fig. 6, red line). The 76.2% accuracy line (Fig. 6, green 
line) of the Profiling Tool lies within the 95% confidence inter-
vals of all accuracy rates except for 1 estimation and 7 valida-
tion sub-samples.
The scatter plot of the accuracy rates of the estimation and 
validation sub-samples for the 100 validation runs shows an in-
verse relationship whereby the more accurate the estimation 
model gets, the less accurate the validation sub-sample esti-
mates becomes (Fig. 7). The point where the accuracy rates of 
the validation and estimation sub-samples are approximately 
equal was 76.0% (Fig. 7, dashed lines). Table 2 shows the accu-
racy rates by cluster for the Profiling Tool and the estimation 
and validation sub-samples. Cluster 1 had the highest accuracy 
rates (90.7%-91.1%). The accuracy rates for the other clusters 
ranged from 66.3% to 73.4%.
Fig. 5. Predictive accuracy rates corresponding to the number of predictor vari-
ables for iHARP variable combinations.
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Table 1. List of questions in the Profiling Tool
S/No. Question Number* Question Response options
  1 Q2a3 I have no time to think about my health as other things are more important Agree/Disagree
  2 Q2a6 I see myself as healthy and fit Agree/Disagree
  3 Q46a2 If someone asked me, I would say I had a stressful life Agree/Disagree
  4 Q2a9 I worry about what my asthma will be like in 10 years Agree/Disagree
  5 Q34a2 My asthma symptoms are not serious Agree/Disagree
  6 Q39a6 I find my inhaler difficult to use Agree/Disagree
  7 Q48a2 I feel embarrassed carrying my asthma inhaler around with me Agree/Disagree
  8 Q48a3 I feel embarrassed using my asthma inhaler in front of others Agree/Disagree
  9 Q48a6 My asthma stops me living life to the full Agree/Disagree
10 Q48a7 My asthma affects my sex life Agree/Disagree
11 - Please enter patient iHARP classification (for doctor use only) Controlled/Partially controlled/Uncontrolled
*Question number as in patient survey questionnaire. See also Supplementary Material.
Estimation
Validation
Original
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DISCUSSION
This study was the first attempt to develop a patient attitudinal-
profiling tool that can help physicians tailor the asthma man-
agement plan for their patients at the point-of-care. Besides the 
physician assessment of the disease condition, the patient’s atti-
tude toward the disease was concurrently evaluated as it has an 
important influence on his/her adherence to the management 
plan and treatment outcome.33 The Profiling Tool contained 10 
simple ‘agree/disagree’ questions for self-completion by the pa-
tient, and a question on the level of asthma control for comple-
tion by the attending physician. We believed that the small num-
ber of questions and simple response structure (agree/disagree) 
would make the tool easy for patients to use. 
We recognized that there could be differences in the socio-
economic profiles of respondents from the countries in the sur-
vey that may limit the effectiveness of the tool. Such differences 
can be expected of a survey spanning a number of countries. 
However, the profile plots for a number of socio-economic and 
disease factors showed that they were, by and large, similar 
across the surveyed countries and the total population. There 
were no indications of bias for these factors in the respondent 
population of any country. The cluster representation of the re-
spondents in each of the surveyed country matched the total 
population. We believe that respondents who had access to so-
cial media may be similar across the surveyed countries, espe-
cially those from the 26-40 years age groups and who used such 
media frequently, and contributed to the uniformity seen in 
these profiles. This may place a limitation on the use of the tool 
beyond the tech-savvy population of the urban centers.
The validation results showed that the discriminant functions 
for the Profiling Tool were robust and accurate in assigning a 
case to one of the 5 attitudinal clusters. Although the predictive 
model from each of the estimation sub-samples used a smaller 
number of cases (about 1,200 cases) compared to the Profiling 
Tool (2,400 cases), its accuracy rate in assigning the cases in the 
validation sub-sample was as good as the tool. These validation 
sub-samples were sufficiently large and could optimally detect 
differences in the predictive accuracy of the estimation models. 
However, there were variations in the accuracy rates (67.8%-
90.7%) at the cluster level, Cluster 5 (worried with multiple 
symptoms) being the lowest and Cluster 1 (well-adjusted and 
at least partly controlled) the highest. The well-adjusted pa-
tients were apparently more consistent in their responses. 
While the tool was most effective in identifying the well-adjust-
ed patients, it remained sufficiently effective for the other clus-
ters. The lowest accuracy rate of 67.8% exceeded the 20.0% lev-
el (i.e., 1 in 5 clusters) that would be expected by chance. Im-
portantly, the tool could identify patients in the most urgent 
need of attention i.e., those who were tolerating (Cluster 4, 
70.6%) or were in denial (Cluster 2, 69.5%) of their poor asthma 
condition, in 7 cases out of 10.
An inherent limitation to our method was how to ensure that 
the sample from which we used for the Profiling Tool, which 
came from a population aged 18 to 50 years with access to so-
cial media, was not peculiar or different from future samples. In 
particular, the management of asthma in the elderly presents 
its own challenges.34 The parameters derived by the DFA maxi-
mized the distinctions between the clusters (i.e., ‘patient attitu-
dinal types’). The key factor for the stability of these parameters 
was that they were not specific to our sample but were also ap-
plicable to other samples. In our survey, the cross-validation 
technique used to address this issue by randomly and repeat-
edly drawing the sample cases from patient populations in all 
the 8 countries/area into the 2 sub-samples proved that the de-
rived parameters were not susceptible to the patient composi-
tion i.e., country, age, gender, or disease status in the sample. 
Had some data points of a sub-sample been peculiar, they 
would affect the tool’s predictability and lower its accuracy rate. 
Low accuracy rates would have meant that our Profiling Tool 
could not be generalized to other samples. Our results showed 
that this was not the case. The accuracy rates of the estimation 
and validation sub-samples (76.7% and 75.3% respectively) 
were comparable to the accuracy of the discriminant functions 
operating in the Profiling Tool (76.2%) in assigning the cases to 
the correct clusters. On average, the tool correctly fitted 3 in ev-
ery 4 cases: an accuracy rate exceeded the expected 20.0% level 
and met our 75.0% benchmark target.30,31 This reinforced our 
view that the discriminant functions used in the Profiling Tool 
were generalizable beyond our population of 2,400 cases. 
Table 2. Accuracy rates of the Profiling Tool, validation sub-sample, and estimation sub-sample by cluster
Cluster
Estimation sub-samples Validation sub-samples Profiling Tool
No. Accuracy rate (%) No. Accuracy rate (%) No. Accuracy rate (%)
Cluster 1 35,157 91.1 35,043 90.7 702 90.7
Cluster 3 15,916 73.4 15,884 70.9 318 72.0
Cluster 4 34,745 70.5 34,555 68.9 693 70.6
Cluster 2 20,739 70.6 20,961 69.3 417 69.5
Cluster 5 13,476 68.4 13,524 66.3 270 67.8
All clusters 120,033 76.7 119,967 75.3 2,400 76.2
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The relationship between the accuracy rates of the estimation 
and validation sub-samples exhibited an inverse relationship 
whereby the more accurate the estimation model, the less ac-
curate the validation sub-sample model estimate. The 76.0% 
point where the 2 accuracy rates were equal was similar to the 
accuracy rate of 76.2% of the tool, which suggested that the dis-
criminant functions for the Profiling Tool have not been over-
fitted. Furthermore, the difference between the accuracy rates 
of estimation and validation sub-samples of 1.4 percentage-
points provided an upper-bound estimate for the degree of 
over-fitting that we can expect using the original 2,400 cases to 
estimate the discriminant functions as the larger sample (2,400 
vs. 1,200) would have generated a smaller confidence interval.
Recommendation
The patient can complete the questions in this Profiling Tool at 
the waiting room prior to the consultation. The attending physi-
cian can input his assessment of the level of asthma control of 
the patient during the consultation. The tool then computes the 
weighted scores using the responses from the patient and phy-
sician to the question items and our discriminant functions, 
and displays the attitudinal cluster which describes the patient 
best. The physician can tailor the asthma management plan for 
the patient using this knowledge of the attitudinal cluster.
While such a profiling tool can be made readily available to 
physicians via the Internet, the challenge would be to integrate 
its use in clinical practice, especially in areas where Internet re-
sources are not available or patients are not comfortable with 
the use of such technology. To use this tool outside the sur-
veyed countries, we suggest that a baseline survey be conduct-
ed to validate the Profiling Tool.
CONCLUSION
Our results showed that our Profiling Tool could identify 
which attitudinal cluster a patient with asthma belongs to and 
enable the physician to make appropriate asthma management 
decisions in practice.
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